Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Da Som Jeon"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Lung and Thoracic cancer
Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015
Da Som Jeon, Ho Cheol Kim, Se Hee Kim, Tae-Jung Kim, Hong Kwan Kim, Mi Hyung Moon, Kyongmin Sarah Beck, Yang-Gun Suh, Changhoon Song, Jin Seok Ahn, Jeong Eun Lee, Jeong Uk Lim, Jae Hyun Jeon, Kyu-Won Jung, Chi Young Jung, Jeong Su Cho, Yoo-Duk Choi, Seung-Sik Hwang, Chang-Min Choi, Korean Association for Lung Cancer, Korea Central Cancer Registry
Cancer Res Treat. 2023;55(1):103-111.   Published online June 20, 2022
DOI: https://doi.org/10.4143/crt.2022.264
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
This study aimed to provide the clinical characteristics, prognostic factors, and 5-year relative survival rates of lung cancer diagnosed in 2015.
Materials and Methods
The demographic risk factors of lung cancer were calculated using the KALC-R (Korean Association of Lung Cancer Registry) cohort in 2015, with survival follow-up until December 31, 2020. The 5-year relative survival rates were estimated using Ederer II methods, and the general population data used the death rate adjusted for sex and age published by the Korea Statistical Information Service from 2015 to 2020.
Results
We enrolled 2,657 patients with lung cancer who were diagnosed in South Korea in 2015. Of all patients, 2,098 (79.0%) were diagnosed with non–small cell lung cancer (NSCLC) and 345 (13.0%) were diagnosed with small cell lung cancer (SCLC), respectively. Old age, poor performance status, and advanced clinical stage were independent risk factors for both NSCLC and SCLC. In addition, the 5-year relative survival rate declined with advanced stage in both NSCLC (82%, 59%, 16%, 10% as the stage progressed) and SCLC (16%, 4% as the stage progressed). In patients with stage IV adenocarcinoma, the 5-year relative survival rate was higher in the presence of epidermal growth factor receptor (EGFR) mutation (19% vs. 11%) or anaplastic lymphoma kinase (ALK) translocation (38% vs. 11%).
Conclusion
In this Korean nationwide survey, the 5-year relative survival rates of NSCLC were 82% at stage I, 59% at stage II, 16% at stage III, and 10% at stage IV, and the 5-year relative survival rates of SCLC were 16% in cases with limited disease, and 4% in cases with extensive disease.

Citations

Citations to this article as recorded by  
  • Patient-Reported Symptoms and Quality of Life With Sacituzumab Govitecan Versus Docetaxel in Metastatic NSCLC: The Phase 3, Randomized EVOKE-01 Trial
    Niels Reinmuth, Sébastien Couraud, Luis Paz-Ares, Marina Chiara Garassino, Shobhit Baijal, Davey Daniel, Pilar Garrido, Terufumi Kato, Ivor Percent, Achim Rittmeyer, Hector Soto Parra, Sabeen Mekan, Mira Patel, Matthew Radford, Eric Zhang, Christopher G.
    JTO Clinical and Research Reports.2026; 7(2): 100929.     CrossRef
  • Exploring Sex and Clinical Factors Associated with Long-Term Survival After Implantable Cardioverter-Defibrillator Implantation: A 10-Year Cohort Study
    Rebeca Lorca, María Salgado, Cristina Helguera, Alberto Alen, Francisco González-Urbistondo, Rosana González-Mesa, Paula Bouzón, Daniel García, Rodrigo Di Massa, Rut Álvarez-Velasco, José Manuel Rubín, Pablo Avanzas
    Journal of Clinical Medicine.2026; 15(3): 1275.     CrossRef
  • Targeting NHEJ activates STING signaling through MYC degradation to boost antitumor immunity in SCLC
    Subhamoy Chakraborty, Andrew Elliott, Utsav Sen, Charles Coleman, Vrinda Jethalia, Kedwin Ventura, Chih-Wei Fan, Ramja Sritharan, Avisek Banerjee, Yazhini Mahendravarman, Ari Vanderwalde, Balazs Halmos, Elisa de Stanchina, Hirokazu Taniguchi, Deniz Demirc
    Nature Communications.2026;[Epub]     CrossRef
  • Formulation of pullulan-assisted nanoparticles for improved dasatinib cytotoxicity in A549 lung carcinoma cells
    Sunita S. Shinde, Aishwarya A. Lohar, Avinash H. Hosmani, Sameer J. Nadaf, Rohit R. Shah
    Zeitschrift für Naturforschung C.2026;[Epub]     CrossRef
  • Fragment-Based De Novo Discovery of Fourth-Generation EGFR-L858R/T790M/C797S-Tyrosine Kinase Inhibitors Targeting Catalytic Lys745 Residue to Overcome the Osimertinib Resistance
    Prasanna Joshi, Manisha Modak, Harun Patel
    Journal of Computational Biophysics and Chemistry.2026; 25(11): 2793.     CrossRef
  • Design and application of a novel acridine-based fluorophore BAA12C as a theranostic agent
    Dat Thanh Dinh, Chia-Ying Li, Ryan Joshua Liou, Xuan-Yu Chen, Min-Wei Wu, Cheng-Chung Chang
    Sensors and Actuators Reports.2026; 11: 100460.     CrossRef
  • Integrated analysis of therapeutic strategies and prognostic factors in advanced lung adenocarcinoma: Retrospective study with emphasis on gene assays, multimodality treatment approaches and predictive machine learning models
    Shingchern You, Shiuan-Wen Chen, Irene Chen, Wei-Teing Chen
    Oncology Letters.2026; 31(5): 1.     CrossRef
  • FTO Acts as a Suppressor Gene to Inhibit the Translation of KDM5A mRNA by Demethylating m6A Modifications in Lung Adenocarcinoma
    Wen Zhao, Chen Zhu, Ning Wang, Bin Wu, Xuelin Lu, Ye Xu, Zhijie Xu
    International Journal of Genomics.2026;[Epub]     CrossRef
  • Identification of Prognostic Risk Factors in Older Patients With Extensive‐Stage Small Cell Lung Cancer
    Jiayin Liu, Xun Liu, Xiaolin Li, Ning Liu, Bo Wang, Li Feng, Zhisong Fan, Long Wang, Jing Han, Xue Zhang, Hui Jin, Dan Li, Yan Liu, Jing Zuo, Yudong Wang
    Cancer Medicine.2026;[Epub]     CrossRef
  • Trends and Outcomes of Lung Cancer Surgery in South Korea
    Joon Beom Park, Su-Jin Cho, Myung-Il Hahm, Danbee Kang, Seong Yong Park
    Cancer Research and Treatment.2026; 58(2): 443.     CrossRef
  • Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review
    Evangeline Samuel, S. Tissera, E. Paul, J. Zalcberg, R. G. Stirling
    Aging and Cancer.2026;[Epub]     CrossRef
  • Real‐World Treatment and Outcomes in Resectable Early‐Stage Non‐Small Cell Cancer: THASSOS‐INTL Australia Cohort
    Pei Ding, Kevin Jasas, Victoria Bray, Abhijit Pal, Rebecca Moor
    AGING MEDICINE.2026; 9(2): 137.     CrossRef
  • Albumin-myosteatosis gauge as predictor of survival time in patients with lung cancer treated with immune checkpoint inhibitors
    Lai Wei, Mengxing Tian, Qian Han, Wen Wang, Xin Jin, Xintian Xu
    Clinical Nutrition ESPEN.2026; 73: 103288.     CrossRef
  • AptoDetect™-Lung Assay as a Blood-Based Predictor of Advanced-Stage Lung Cancer in Patients with Lung-RADS 3–4 Pulmonary Nodules: A Multicenter Prospective Cohort Study
    Bora Lee, Chi Young Kim, Jung Seop Eom, Wonjun Ji, Min Jee Kim, Sung Hoon Yoon, June Hong Ahn, Jun Hyeok Lim, Chaeuk Chung, Dong Won Park, Seung Hyeun Lee, Chang Dong Yeo
    Biomedicines.2026; 14(5): 1013.     CrossRef
  • Functional Precision Oncology Approach Using Nanoliter Droplet Array for Drug Sensitivity Testing in Lung Cancer
    Maryam Salarian, Vicky L. Schiling, Thomas Muley, Michael Allgäuer, Florian Eichhorn, Michael Meister, Marc A. Schneider, Anna A. Popova
    Advanced Healthcare Materials.2026;[Epub]     CrossRef
  • Differences in long-term survival according to the underlying cardiomyopathy indication for implantable cardioverter-defibrillator implantation
    Rebeca Lorca, Paula Bouzón, Fernando López, María Salgado, Rosana González-Mesa, Francisco González-Urbistondo, Cristina Helguera, Alberto Alen, Alvaro Lorente, Rut Alvarez-Velasco, José Manuel Rubín, Pablo Avanzas
    International Journal of Cardiology.2026; 458: 134561.     CrossRef
  • SLC2A1-Dependent Ketone Metabolism Regulates Tumor Progression and Immunotherapy Efficacy in Lung Adenocarcinoma
    Xing Feng, Li Gao, Yonggang Xue, Yanbing Zhang, Hongyou Cao, Tianchang Wange
    Critical Reviews in Immunology.2026; 46(2): 59.     CrossRef
  • Weight loss as a predictor of reduced survival in patients with lung cancer: a systematic review with meta-analysis
    Junfang Zhang, Xuan Tang, Wenbo Zhang, Ying Xu, Heng Zhang, Yu Fan
    International Journal of Obesity.2025; 49(1): 13.     CrossRef
  • Preclinical safety and effectiveness of a long-acting somatostatin analogue [225Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors
    Fabrice N. Njotu, Jessica Pougoue Ketchemen, Hanan Babeker, Nikita Henning, Anjong F. Tikum, Emmanuel Nwangele, Alissar Monzer, Nava Hassani, Brian D. Gray, Koon Y. Pak, Emina E. Torlakovic, Maruti Uppalapati, Humphrey Fonge
    European Journal of Nuclear Medicine and Molecular Imaging.2025; 52(4): 1305.     CrossRef
  • Interactions and communications in lung tumour microenvironment: chemo/radiotherapy resistance mechanisms and therapeutic targets
    Yuan Feng, Ying Jiang, Lin Yang, Danni Lu, Ning Li, Qun Zhang, Haiyan Yang, Huiyuan Qin, Jiaxin Zhang, Xinyun Gou, Feng Jiang
    Journal of Drug Targeting.2025; 33(6): 817.     CrossRef
  • The systematic analysis of genes related to butyrate metabolism suggests that CDKN3 could serve as a promising therapeutic target for lung adenocarcinoma treatment
    Yanchao Luan, Chao Liang, Qingsong Han, Xueqin Zhou, Na Yang, li Zhao
    BMC Cancer.2025;[Epub]     CrossRef
  • Secretome and Proteome of Extracellular Vesicles Provide Protein Markers of Lung and Colorectal Cancer
    Natalia Soloveva, Svetlana Novikova, Tatiana Farafonova, Olga Tikhonova, Victor Zgoda
    International Journal of Molecular Sciences.2025; 26(3): 1016.     CrossRef
  • Baseline 18F-FDG PET/CT parameters in predicting the efficacy of immunotherapy in non-small cell lung cancer
    Lu Zheng, Yanzhu Bian, Yujing Hu, Congna Tian, Xinchao Zhang, Shuheng Li, Xin Yang, Yanan Qin
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Artificial intelligence-assisted point-of-care devices for lung cancer
    Xin Jie Keith Ng, Anis Salwa Mohd Khairuddin, Hai Chuan Liu, Thian Chee Loh, Jiunn Liang Tan, Sook Mei Khor, Bey Fen Leo
    Clinica Chimica Acta.2025; 570: 120191.     CrossRef
  • Genetic Navigation: A Narrative Review of XRCC1 Polymorphism Impact on Platinum-Based Chemotherapy Outcomes in NSCLC Patients
    Lanny Permatasari, Nadiya Afifah, Maryam Ishmatullah, Ruri Intania, Eli Halimah, Melisa Barliana
    Cancer Management and Research.2025; Volume 17: 383.     CrossRef
  • Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study
    Qi-An Wang, I-Lin Tsai, Chien-Yu Lin, Po-Lan Su, Chien-Chung Lin, John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Chih-Hsi Scott Kuo, Ping-Chih Hsu, Cheng-Ta Yang, Chiao-En Wu
    Therapeutic Advances in Medical Oncology.2025;[Epub]     CrossRef
  • Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis
    Jenny Zipprick, Enes Demir, Hanna Krynska, Sıla Köprülüoğlu, Katharina Strauß, Marcus Skribek, Rita Hutyra-Gram Ötvös, Annica K. B. Gad, Katalin Dobra
    Cancers.2025; 17(6): 986.     CrossRef
  • Defining long-term survivors in metastatic lung cancer: insights from a Delphi study in Spain
    Enric Carcereny, Manuel Domine, Ana Laura Ortega Granados
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Genomics and the early diagnosis of lung cancer
    Francesco Pepe, Tancredi Didier Bazan Russo, Valerio Gristina, Andrea Gottardo, Giulia Busuito, Giuliana Iannì, Gianluca Russo, Claudia Scimone, Lucia Palumbo, Lorena Incorvaia, Giuseppe Badalamenti, Antonio Galvano, Viviana Bazan, Antonio Russo, Giancarl
    Personalized Medicine.2025; 22(3): 161.     CrossRef
  • Single-cell transcriptomics and machine learning unveil ferroptosis features in tumor-associated macrophages: Prognostic model and therapeutic strategies for lung adenocarcinoma
    Ting Ji, Juanli Jiang, Xin Wang, Kai Yang, Shaojin Wang, Bin Pan
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Senescence-associated secretory phenotype in lung cancer: remodeling the tumor microenvironment for metastasis and immune suppression
    Chen Chen, Ji Chen, Yanling Zhang, Qijun Zhang, Haixia Shi
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • A Systematic Review and Meta-Analysis of the Efficacy and Safety of Lazertinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Louis Fabio Jonathan Jusni, Eric Ricardo Yonatan, Nicolas Daniel Widjanarko, Rio Gusta Notario Besri
    Hematology/Oncology and Stem Cell Therapy.2025; 18(2): 48.     CrossRef
  • The predictive value of ferroptosis marker SLC7A11 in the prognosis of advanced non-small cell lung cancer patients
    Shiqiang Wang, Xinlai Jin, Xuefei Yang, Zhidi Zhang
    Clinical Biochemistry.2025; 138: 110961.     CrossRef
  • p53 aberrant expression is pervasive in pleomorphic carcinomas of the lung and a sensitive diagnostic adjunct for biopsy specimens
    Joshua Jing Xi Li, Chit Chow, Joanna Ka Man Ng, Ka Pang Chan, Molly Siu Ching Li, Ka-Fai To
    Diagnostic Pathology.2025;[Epub]     CrossRef
  • Diagnostic performance of artificial intelligence models for pulmonary nodule classification: a multi-model evaluation
    Sarah K. Herber, Lukas Müller, Daniel Pinto dos Santos, Tobias Jorg, Fabio Souschek, Tobias Bäuerle, Sebastian Foersch, Christian Galata, Peter Mildenberger, Moritz C. Halfmann
    European Radiology.2025; 36(1): 537.     CrossRef
  • Small-Cell Lung Cancer Updates
    Yunan Nie, Anne C. Chiang
    Seminars in Respiratory and Critical Care Medicine.2025; 46(05): 467.     CrossRef
  • A shape complementarity strategy based on NCA029 enables potent HsClpP agonists for the treatment of small cell lung carcinoma
    Linjie Li, Baozhu Luo, Xudong Wang, Zhongyu Jian, Hong Liu, Bo Ren, Wenliang Qiao, Youfu Luo, Tao Yang
    European Journal of Medicinal Chemistry.2025; 299: 118008.     CrossRef
  • CLDN4 regulates cell proliferation in small cell lung cancer cells via SAA1 inhibition
    Korehito Kashiwagi, Hanako Sato-Yazawa, Jun Ishii, Masami Iwamoto, Kakeru Kohno, Tadasuke Miyazawa, Tamotsu Kamimura, Shunsuke Miyata, Ruri Sugiyama, Hideki Chiba, Takuya Yazawa
    Biochemical and Biophysical Research Communications.2025; 785: 152710.     CrossRef
  • Autophagy inhibition enhances sensitivity of alpelisib in PI3K–mutated non-small cell lung cancer
    Jinyoung Kim, Chandani Shrestha, Tae Woo Kim, Sang-Bin Lee, Gwangbin Lee, Dasom Jung, Min Hwang, Shinwon Kang, Hyung Soon Park, Hyunho Kim, Ho Jung An, Dongwoo Chae, Byoung Yong Shim, Jiyoon Kim
    Biomedicine & Pharmacotherapy.2025; 192: 118620.     CrossRef
  • Lung Cancer Management: A Comprehensive Review with Special Focus on Natural Remedies and Bioactive Compounds
    Raj Shekhar, P. Muralidharan, Namrata Hallur, S. B. Puranik, Phatru Patel
    Journal of Natural Remedies.2025; : 1989.     CrossRef
  • Ferroptosis and non-coding RNAs in lung cancer: exploring molecular mechanisms and diagnostic/therapeutic implications
    Hedong Xue, Melika Malek, Liangyu Li
    Cancer Cell International.2025;[Epub]     CrossRef
  • Association of Pre‐ and Postdiagnosis Physical Activity, Promotion and Maintenance With Lung Cancer Survival: A Nationwide Cohort Study
    Yeon Wook Kim, Kyeong Im Kwak, A‐Reum Choi, Eung Joo Park, Brian J. Lee, Yeon Joo Lee, Choon‐Taek Lee
    Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub]     CrossRef
  • Directions of Immunotherapy for Non-Small-Cell Lung Cancer Treatment: Past, Present and Possible Future
    Gian Marco Leone, Grazia Scuderi, Paolo Fagone, Katia Mangano
    International Journal of Molecular Sciences.2025; 26(22): 11055.     CrossRef
  • Radiogenomic insights from a Portuguese lung cancer cohort: Foundations for predictive modeling
    Inês Neves, Cláudia Freitas, Carolina Lemos, Hélder P. Oliveira, Venceslau Hespanhol, Manuela França, Tania Pereira
    Measurement and Evaluations in Cancer Care.2025; 3: 100025.     CrossRef
  • Hyperthermic Intrathoracic Chemotherapy and Photodynamic Therapy: A Single-Institution Experience for Malignant Pleural Diseases
    Yu-An Zheng, Ke-Cheng Chen, Pei-Ming Huang, Mong-Wei Lin, Shuenn-Wen Kuo, Jang-Ming Lee
    Oncology.2025; : 1.     CrossRef
  • Lung Cancer Outcomes in Vietnam: A 6-Year Retrospective Study
    Khanh Toan Nguyen, Thi Huong Pham, Van Lam Ngo, Thi Thuy My Nguyen, Thi Dao Nguyen, Van Thanh Le, Van Nhat Nguyen, Thi Thanh Thuy Nguyen, Khanh Ha Nguyen, Thi Nhung Ngo, Thi Hai Yen Le, Thi Phuong Thao Nguyen, Thi Ha Phuong Nguyen, Thi Hong Anh Vo, Thi Th
    Journal of Immunotherapy and Precision Oncology.2025; 8(4): 254.     CrossRef
  • Spatial Dynamics of Tumor Cell Plasticity in Lung Adenocarcinoma Revealed by Region‐Specific Single Cell Transcriptomics
    Anna A. Khozyainova, Maxim E. Menyailo, Vera G. Subrakova, Dmitry M. Loos, Pavel S. Iamshchikov, Anton A. Fedorov, Maria S. Tretyakova, Ustinia A. Bokova, Evgeny O. Rodionov, Sergey V. Miller, Evgeny B. Topolnitsky, Denis V. Piankov, Sergei A. Korostelev,
    Genes, Chromosomes and Cancer.2025;[Epub]     CrossRef
  • Inflammatory cytokine-associated cisplatin resistance in non-small cell lung cancer and re-sensitization through interleukin-6 receptor blockade
    Gizem Calibasi-Kocal
    World Journal of Clinical Oncology.2025;[Epub]     CrossRef
  • Anti-cancer Effects of Sargassum micracanthum Extract on Non-small Cell Lung Cancer Cells
    Hyun-Ji Park, Seon-Eun Park, Gyoo-Yong Chi, Yung-Hyun Choi, Shin-Hyung Park
    Journal of Physiology & Pathology in Korean Medicine.2025; 39(5): 120.     CrossRef
  • Clinical Impact of Genomic and Pathway Alterations in Stage I EGFR-Mutant Lung Adenocarcinoma
    Jae Seok Lee, Eun Kyung Kim, Kyung A Kim, Hyo Sup Shim
    Cancer Research and Treatment.2024; 56(1): 104.     CrossRef
  • The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline Round
    Alberto Antonicelli, Piergiorgio Muriana, Giovanni Favaro, Giuseppe Mangiameli, Ezio Lanza, Manuel Profili, Fabrizio Bianchi, Emanuela Fina, Giuseppe Ferrante, Simone Ghislandi, Daniela Pistillo, Giovanna Finocchiaro, Gianluigi Condorelli, Rosalba Lembo,
    Cancers.2024; 16(2): 417.     CrossRef
  • Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer
    Hyeon Hwa Kim, Jae Cheol Lee, In-Jae Oh, Eun Young Kim, Seong Hoon Yoon, Shin Yup Lee, Min Ki Lee, Jeong Eun Lee, Chan Kwon Park, Kye Young Lee, Sung Yong Lee, Seung Joon Kim, Jun Hyeok Lim, Chang-min Choi
    Cancers.2024; 16(3): 528.     CrossRef
  • Lung Cancer Proteogenomics: Shaping the Future of Clinical Investigation
    Theofanis Vavilis, Maria Louiza Petre, Giannis Vatsellas, Alexandra Ainatzoglou, Eleni Stamoula, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas, Ioannis N. Vamvakaris, Ioannis Gkiozos, Konstantinos N. Syrigos, Athanasios K. Anagnostopoulos
    Cancers.2024; 16(6): 1236.     CrossRef
  • Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing
    Rebeca Lorca, María Salgado, Rut Álvarez-Velasco, Julián R. Reguro, Vanesa Alonso, Juan Gómez, Eliecer Coto, Elías Cuesta-Llavona, Eva Lopez-Negrete, Isaac Pascual, Pablo Avanzas, Maite Tome
    International Journal of Cardiology.2024; 408: 132117.     CrossRef
  • 18F-Fluorodeoxyglucose Positron Emission Tomography-Based Risk Score Model for Prediction of Five-Year Survival Outcome after Curative Resection of Non-Small-Cell Lung Cancer
    Chae Hong Lim, Sang-Won Um, Hong Kwan Kim, Yong Soo Choi, Hong Ryul Pyo, Myung-Ju Ahn, Joon Young Choi
    Cancers.2024; 16(14): 2525.     CrossRef
  • Study Progress of Circulating miRNA for Predicting Metastasis in Non-Small Cell Lung Cancer
    靖靖 丛
    Advances in Clinical Medicine.2024; 14(07): 65.     CrossRef
  • Toll-like Receptors: Key Players in Squamous Cell Carcinoma Progression
    Jolanta Smok-Kalwat, Paulina Mertowska, Sebastian Mertowski, Stanisław Góźdź, Ewelina Grywalska
    Journal of Clinical Medicine.2024; 13(15): 4531.     CrossRef
  • Timing of Palliative Care Consultation Impacts End of Life Care Outcomes in Metastatic Non-Small Cell Lung Cancer
    Cameron J. Oswalt, Morgan M. Nakatani, Jesse Troy, Steven Wolf, Susan C. Locke, Thomas W. LeBlanc
    Journal of Pain and Symptom Management.2024; 68(4): e325.     CrossRef
  • Enhanced Lung Cancer Detection Using a Combined Ratio of Antigen–Autoantibody Immune Complexes against CYFRA 21-1 and p53
    Heyjin Kim, Jin Kyung Lee, Hye-Ryoun Kim, Young Jun Hong
    Cancers.2024; 16(15): 2661.     CrossRef
  • Discrimination of Lung Cancer and Benign Lung Diseases Using BALF Exosome DNA Methylation Profile
    Chinbayar Batochir, In Ae Kim, Eun Ji Jo, Eun-Bi Kim, Hee Joung Kim, Jae Young Hur, Do Won Kim, Hee Kyung Park, Kye Young Lee
    Cancers.2024; 16(15): 2765.     CrossRef
  • The clinical significance of endoplasmic reticulum stress related genes in non-small cell lung cancer and analysis of single nucleotide polymorphism for CAV1
    Shuang Li, Junting Chen, Baosen Zhou
    Frontiers in Molecular Biosciences.2024;[Epub]     CrossRef
  • A Highly Sensitive Toluene Gas Sensor Based on Pd/PdO Decorated SnO2 Prepared by Electrospinning
    Chengyi Gong, Meng Chen, Fei Song, Peisi Yin, Xin Zhao, Xiaoyu You, Huaian Fu, Shanshan Yu, Xingyu Liu, Kai Zhang, Yongqi Yang, Zhipeng Tang, Xiangmin Du, Jiacong Xu, Qiang Jing, Bo Liu
    ACS Applied Electronic Materials.2024;[Epub]     CrossRef
  • miR-137: a potential therapeutic target for lung cancer
    Shuanshuan Liu, Yanyun Ruan, Xu Chen, Bao He, Qi Chen
    Frontiers in Cell and Developmental Biology.2024;[Epub]     CrossRef
  • Discovery of CLKs inhibitors for the treatment of non-small cell lung cancer
    Tianxing Hu, Jiali Huang, Rui Chen, Hui Zhang, Mai Liu, Renbing Wang, Wenyi Zhou, Dechun Huang, Mingkang Cao, Depeng Li, Zhiyu Li, Hongxi Wu, Jinlei Bian
    European Journal of Medicinal Chemistry.2024; 280: 116952.     CrossRef
  • CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma
    Suet Kee Loo, Gabriel Sica, Xian Wang, Tingting Li, Luping Chen, Autumn Gaither-Davis, Yufei Huang, Timothy F. Burns, Laura P. Stabile, Shou-Jiang Gao
    Cell & Bioscience.2024;[Epub]     CrossRef
  • Methylation modification is a poor prognostic factor in non-small cell lung Cancer and regulates the tumor microenvironment: mRNA molecular structure and function
    Kai Yang, YuPing Yang, Lin Yu, Fan Yang, YuXin Xiang, Jun Zeng, Na Huang
    International Journal of Biological Macromolecules.2024; 282: 137214.     CrossRef
  • Impact of Postoperative Prolonged Air Leakage on Long-Term Pulmonary Function after Lobectomy for Lung Cancer
    June Yeop Lee, Joonseok Lee, Varissara Javakijkarnjanakul, Beatrice Chia-Sui Shih, Woohyun Jung, Jae Hyun Jeon, Kwhanmien Kim, Sanghoon Jheon, Sukki Cho
    Journal of Chest Surgery.2024; 57(6): 511.     CrossRef
  • M1 macrophage-related prognostic model by combining bulk and single-cell transcriptomic data in NSCLC
    Liu Zhe, Liu Fang, Petinrin Olutomilayo Olayemi, Toseef Muhammad, Chen Nanjun, Zhu Zhongxu, Wong Ka-Chun
    Exploration of Medicine.2024;[Epub]     CrossRef
  • Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring
    Michele Tomanelli, Federica Guffanti, Giulia Vargiu, Edoardo Micotti, Mara Rigamonti, Francesca Tumiatti, Elisa Caiola, Mirko Marabese, Massimo Broggini
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Combinatorial Blood Platelets-Derived circRNA and mRNA Signature for Early-Stage Lung Cancer Detection
    Silvia D’Ambrosi, Stavros Giannoukakos, Mafalda Antunes-Ferreira, Carlos Pedraz-Valdunciel, Jillian W. P. Bracht, Nicolas Potie, Ana Gimenez-Capitan, Michael Hackenberg, Alberto Fernandez Hilario, Miguel A. Molina-Vila, Rafael Rosell, Thomas Würdinger, Da
    International Journal of Molecular Sciences.2023; 24(5): 4881.     CrossRef
  • Low diffusion capacity predicts poor prognosis in extensive stage small cell lung cancer: a single-center analysis of 10 years
    Jee Seon Kim, Eun Ji Kim, Jong Geol Jang, Kyung Soo Hong, June Hong Ahn
    Journal of Cancer Research and Clinical Oncology.2023; 149(10): 7275.     CrossRef
  • Prior treated tuberculosis and mortality risk in lung cancer
    Kuang-Ming Liao, Chung-Shu Lee, Yu-Cih Wu, Chin-Chung Shu, Chung-Han Ho
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • All-round counterattack to conquer lung cancer
    Seung Hun Jang
    Journal of the Korean Medical Association.2023; 66(3): 154.     CrossRef
  • Metabolic profiles of lung adenocarcinoma via peripheral blood and diagnostic model construction
    Kyung Soo Kim, Seok Whan Moon, Mi Hyung Moon, Kwan Yong Hyun, Seung Joon Kim, Young Koon Kim, Kwang Youl Kim, Dong Wook Jekarl, Eun-Jee Oh, Yonggoo Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • STEMI in women. Life expectancy recovery after primary percutaneous coronary intervention
    Marcel Almendárez, Rut Álvarez-Velasco, Pablo Avanzas, Alberto Alperi, Luis Gutiérrez, David Ledesma, Javier Martínez, Daniel Hernández-Vaquero, Rebeca Lorca, Luis Arboine, Cesar Morís, Isaac Pascual
    Revista Española de Cardiología (English Edition).2023; 76(12): 1003.     CrossRef
  • A Retrospective Analysis Comparing VATS Cost Discrepancies and Outcomes in Primary Lung Cancer vs. Second Primary Lung Cancer Patients
    Bogdan Cosmin Tanase, Alin Ionut Burlacu, Claudiu Eduard Nistor, Teodor Horvat, Cristian Oancea, Monica Marc, Emanuela Tudorache, Tudor Mateescu, Diana Manolescu
    Healthcare.2023; 11(12): 1745.     CrossRef
  • IAMCEST en mujeres. Recuperación de la expectativa de vida tras la intervención coronaria percutánea
    Marcel Almendárez, Rut Álvarez-Velasco, Pablo Avanzas, Alberto Alperi, Luis Gutiérrez, David Ledesma, Javier Martínez, Daniel Hernández-Vaquero, Rebeca Lorca, Luis Arboine, Cesar Morís, Isaac Pascual
    Revista Española de Cardiología.2023; 76(12): 1003.     CrossRef
  • Synthetic Tabular Data Based on Generative Adversarial Networks in Health Care: Generation and Validation Using the Divide-and-Conquer Strategy
    Ha Ye Jin Kang, Erdenebileg Batbaatar, Dong-Woo Choi, Kui Son Choi, Minsam Ko, Kwang Sun Ryu
    JMIR Medical Informatics.2023; 11: e47859.     CrossRef
  • Exosomes in lung cancer metastasis, diagnosis, and immunologically relevant advances
    Jianhua Zhao, Xiwen Li, Lele Liu, Zhen Zhu, Chunyan He
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • 19,803 View
  • 604 Download
  • 91 Web of Science
  • 79 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP